Albemarle Corporation (ALB) FY2025 Earnings Quality Report

Grade: F — Major Red Flags

Framework: Schilit *Financial Shenanigans* + Beneish M-Score + forensic accounting principles

Data: SEC EDGAR 10-K (Filed 2026-02-11, FY ended December 31, 2025) + 10-K/A (2026-03-31) + Yahoo Finance

Auditor: PricewaterhouseCoopers LLP — Unqualified opinion

One-line verdict: Albemarle is a lithium producer in the midst of an industry-wide price collapse. Revenue cratered from $9.6 billion (FY2023) to $5.1 billion (FY2025) as lithium prices fell approximately 80% from their 2022 peaks. Gross margin collapsed from 42.0% (FY2022) to 1.2% (FY2024) before partially recovering to 13.0% (FY2025) as cost-cutting took hold. The company posted consecutive net losses — $1.18 billion (FY2024) and $511 million (FY2025) — while CFFO remained negative relative to net income for three straight years. Three critical red flags fire: CFFO persistently below net income, cash covering only 49% of $3.3 billion debt, and Debt/EBITDA at 10.5x with interest coverage of just 0.3x. The company converted its preferred stock (7.25% Series A Mandatory Convertible) at an approximate market cap of $7.4 billion. This is a cyclical commodity business in deep distress.

The Lithium Bust: Revenue Halved in Two Years

The gross margin story is extraordinary: from 42% in the lithium boom year (FY2022) to 1.2% in FY2024 (essentially break-even on a gross basis) to 13% in FY2025 as Albemarle cut production costs. Revenue declined 44% from the FY2023 peak.

The 10-K/A filing is an Amendment No. 1 solely to add the financial statements of Windfield Holdings Pty Ltd (an equity method investee) as required under Rule 3-09. The amendment states Windfield "was significant under Rule 3-09 for the fiscal year ended December 31, 2023, but not for the fiscal years ended December 31, 2025 and 2024" — meaning the joint venture's significance has diminished alongside lithium prices.

Cash Flow: Recovering From Deep Negative

CFFO has been below net income for three consecutive years — a critical red flag. In FY2023, despite $1.57 billion net income, CFFO was only $1.33 billion (0.84x). In FY2024-2025, net losses made the ratio negative but CFFO remained positive.

The positive development: FCF turned positive at $692 million in FY2025 as CapEx was slashed 65% from $1.68 billion to $590 million. This is aggressive capacity investment cutback as Albemarle conserves cash during the downturn.

The 18-Point Screening

Revenue Quality

Revenue quality is clean. AR declining faster than revenue is healthy. CFFO growth of 86% while revenue declined 4.4% reflects cost-cutting and working capital improvement.

Expense Quality

B3: SG&A at 82.3% of gross profit is alarming, but it reflects the collapsed gross profit denominator — when gross margin is only 13%, fixed SG&A costs consume a larger share. This ratio will normalize when (if) lithium prices recover.

B4: The 11.8 percentage point swing in gross margin is actually improvement — from near-zero to 13%. But the volatility itself (42% to 1.2% to 13.0% over three years) demonstrates extreme commodity cyclicality.

Cash Flow Quality

C1 is a genuine concern. Three years of CFFO below net income raises questions about earnings quality. However, in Albemarle's case, the net losses in FY2024-2025 make the ratio mechanically negative even though CFFO is positive. The FY2023 ratio of 0.84x when net income was $1.57 billion is the more informative data point — and it was below 1.0x.

C4: $1.6 billion cash against $3.3 billion debt provides 49% coverage — the best among the 10 companies in this batch, but still a fail under the framework. Debt declined from $4.3 billion to $3.3 billion over two years, showing active deleveraging.

Balance Sheet

D2 is the critical flag. Debt/EBITDA of 10.5x and interest coverage of 0.3x signal genuine financial stress. When a company cannot cover its interest expense from EBIT, it is operating on borrowed time unless the cycle turns. The Series A Mandatory Convertible Preferred Stock at 7.25% adds to the cash burden.

D3: The 482% increase in other assets requires investigation. This likely reflects reclassification or recognition of long-term assets related to lithium extraction rights, joint venture investments, or deferred tax assets accumulated during loss years.

Acquisition Risk

Manipulation Score

The M-Score is clean, which is expected — Albemarle's problems are operational and cyclical, not accounting manipulation.

Key Risks from the 10-K

1. Lithium Price Uncertainty — No Visibility

Lithium carbonate prices fell approximately 80% from 2022 peaks. While Albemarle has restructured costs, there is no visibility on when — or whether — prices will recover to levels that support profitable operations. The EV adoption rate, Chinese lithium production capacity, and battery chemistry changes (sodium-ion competition) all create demand uncertainty.

2. Interest Coverage Crisis

At 0.3x interest coverage, Albemarle is not generating enough operating income to cover its interest expense. This is survivable short-term with $1.6 billion cash, but unsustainable if the cycle doesn't turn. The 7.25% Mandatory Convertible Preferred Stock adds to the cash burn.

3. Windfield Joint Venture

The 10-K/A filing exists solely to add Windfield Holdings financial statements. While Windfield was "not significant" in FY2024-2025, the filing of separate financial statements under Rule 3-09 indicates this is a material equity method investment that could create additional volatility in Albemarle's results.

4. CapEx Cut-Back Risk

Slashing CapEx from $2.2 billion to $590 million preserves cash but risks underinvesting in capacity that will be needed when the cycle turns. If lithium prices recover and Albemarle lacks the production capacity to benefit, the cuts will prove shortsighted.

Summary

Grade: F. Genuine financial stress from a cyclical commodity collapse, confirmed by 0.3x interest coverage and three years of CFFO below net income.

Albemarle is in survival mode. The company has made rational decisions — cutting CapEx 65%, reducing debt from $4.3 billion to $3.3 billion, improving gross margin from 1.2% to 13.0%, and turning FCF positive. The M-Score is clean at -3.62, and revenue quality checks all pass.

But the balance sheet does not lie: Debt/EBITDA of 10.5x and interest coverage of 0.3x are distress-level metrics. Two consecutive years of net losses totaling $1.69 billion have eroded equity. If lithium prices do not recover within the next 12-18 months, Albemarle may need to raise additional equity (diluting shareholders), sell assets, or restructure debt. The 7.25% mandatory convertible preferred already signals the company has accessed expensive capital.

This is a cyclical bet, not a financial fraud — the M-Score confirms clean accounting. But the screening framework correctly identifies it as high-risk.

**Disclaimer**: This report is based on Albemarle's FY2025 10-K filed with SEC EDGAR on February 11, 2026, and 10-K/A amendment filed March 31, 2026. This is NOT investment advice.

Data: SEC EDGAR 10-K + 10-K/A + Yahoo Finance

Auditor: PricewaterhouseCoopers LLP (Unqualified opinion)

Fiscal year ended: December 31, 2025